Front Street Capital Management, Inc. Merck & Co., Inc. Transaction History

Front Street Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $40,072 - $43,608	400 Added 29.65%	1,749 $191,000
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $138,879 - $154,231	1,349 New	1,349 $139,000
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $203,761 - $239,610	-3,532 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $7,624 - $8,958	-150 Reduced 4.07%	3,532 $214,000
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $187,634 - $218,084	3,682 New	3,682 $201,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Front Street Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Front Street Capital Management, Inc. with notifications on news.